Page 32 - Londra Gazete Sayı 1095
P. 32
Londra Gazete, 03 March 2022 LondraGazete.com/English 9
New regulations from Government
to crack down on ‘botched’ botox
THE government is set to im-
pose new licence requirements
on unregulated cosmetic surgery
providers in an effort to battle
‘botched botox’ procedures.
Changes to Health and Care le-
gislation will be made on Tuesday
which give the government’s he-
alth secretary powers to enforce
a new licencing regime for botox
and fillers.
The move follows a ban on
Pregnancy risk tool cuts baby these procedures for under 18s
in England and comes amid an
loss in ethnic minority women “unacceptable” rise in people be-
ing mentally and physically har- The scope and scale of the new Work is also being done by the
A new pregnancy screening tool limited. med following these procedures. regulation and licence require- Medicines and Healthcare pro-
cuts the risk of baby loss among The new digital tool, which uses The new law will make it illegal ments are yet to be determined ducts Regulatory Agency on the
women from black, Asian and ethnic an algorithm to calculate a woman's for these treatments to be admi- but the government said it will potential to bring certain devices,
minority(BAME) backgrounds to the personal risk, can detect high-risk nistered without a licence and seek to introduce “consistent such as dermal fillers without a
same level as white women, research women more accurately and prevent will ban adverts on all forms of standards” and hygiene and sa- medical purpose, in scope of me-
suggests. complications in pregnancy, the re- media which target under 18s. fety standards. dical device regulations.
The app calculates a woman's indi- searchers say.
vidual risk of pregnancy problems. Both pregnant women and mater-
In a study of 20,000 pregnant nity staff can upload information on `
women, baby death rates in ethnic their pregnancy and how they are
groups were three times lower than feeling to the app during antenatal Experts warn 'Misleading' baby
normal when the tool was used. Ex- appointments and at other times.
In the study, there were nearly 8
perts say the new approach can help baby deaths per 1,000 births among food labels are confusing parents
reduce health inequalities.
The screening tool is already in use mothers from ethnic minority back-
at St George's Hospital in London grounds, compared with 2.63 deaths NEW parents are being war- direct health benefit, known as completely free from sugar, it is
and is being tried out at three oth- per 1,000 births among white moth- ned to be mindful of 'mislea- the 'healthy halo effect'. feared.
er maternity units in England, with ers, when the current checklist was ding' marketing tactics used by Some products described as University of Glasgow resear-
hopes it could be rolled out to 20 cen- used to assess risk. baby food makers. having 'vegetable tastes' can ac- chers analysed 724 baby foods
tres within two years. But in pregnant women using the Experts say promotional ma- tually contain a higher propor- - intended for infants up to 12
In the UK, pregnancy risks are algorithm tool, there was no differ- terial on the packaging of pro- tion of fruit which are naturally months - sold by Aldi, Amazon,
much higher for women from ethnic ence in baby death rates between ducts is confusing parents and more sugary. Asda, Lidl, Tesco, Sainsbury's,
minority backgrounds. white and non-white ethnic groups, fuelling childhood obesity. Wording like 'no added su- Waitrose, and Morrisons.
The current system of a tick-box because three out of four deaths The wording is largely unregu- gar' could also lead parents to It comes as the baby food mar-
checklist to assess pregnancy risk linked to placenta problems had lated and often implies some in- wrongly believe that items are ket in the UK booms, growing
has been around for 70 years, and is been avoided.
2.5 per cent a year, with the
market predicted to reach £1bil-
Sickle cell patients given new ‘life- lion by 2024.
But experts say the absence of
saving’ treatment on the NHS any legally binding regulations
for the composition and promo-
A A new “life-changing” treat- year will be eligible for the treat- tion of manufactured baby foo-
ment has been rolled out to sickle ment. ds mean the market is 'somet-
cell patients through the NHS which According to the NHS, as many as hing of a free-for-all'.
will benefit thousands of people liv- 5,000 people will be treated over the The survey, published in the
ing with the illness. next three years as a result of this Archives of Disease in Childho-
The new treatment, crizanlizum- deal – much earlier than would have od, revealed baby food products
ab, will reduce chronic pain and otherwise been possible. products sold in the UK had a
trips to A&E while improving pa- Sickle cell disease is a serious and total of 6,265 promotional cla-
tients’ quality of life, healthcare lifelong health condition causing ims, with an average of nine per
providers have said. severe pain and organ failure often product. Some carried up to 17.
Loury Mooruth, 62, from Wal- requiring hospital admissions. The main composition claim
sall in the West Midlands, is one of Living with this condition can was 'organic', nutrient claims
the first people to receive the drug make it difficult for many patients were mainly around 'no added'
at Birmingham NHS Trust – the to continue in their jobs or other or 'less' sugar, and the most
first new treatment for the disease everyday activities. common health claim was about
in over two decades. Crizanlizum- This new treatment will initially the role of iron in supporting
ab, delivered by a transfusion drip, only be made available to around normal cognitive development.
works by binding to a protein in the 300 patients but will be extended More than half of the items
blood cells to prevent the restriction to 450 in future years after the de- referenced nutritional benefits,
of blood and oxygen supply that cision by the National Institute for with claims of 'no added' or 'less'
leads to a sickle cell crisis. Health and Care Excellence (Nice), sugar and/or salt present on ne-
People aged over 16 who suffer which recommended the drug be arly 60 per cent.
from multiple sickle cell crises every available on the NHS.